Journal article
BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan
Abstract
INTRODUCTION: Real-world data on COVID-19 vaccine effectiveness are needed to validate evidence from randomized clinical trials. Accordingly, this study aims to evaluate, in a real-world setting in Brazil, the effectiveness of Pfizer-BioNTech BNT162b2 against symptomatic COVID-19 and COVID-19-related complications across diverse populations.
MATERIALS AND METHODS: A test-negative case-control study with follow-up of cases is currently being …
Authors
Rosa RG; Spinardi J; Allen KE; Manfio J; de Araujo CLP; Cohen M; Robinson CC; Sganzerla D; Ferreira D; de Souza EM
Journal
PLOS ONE, Vol. 17, No. 10,
Publisher
Public Library of Science (PLoS)
DOI
10.1371/journal.pone.0276384
ISSN
1932-6203